Literature DB >> 29316241

Expanding clarity or confusion? Volatility of the 5-tier ratings assessing quality of transplant centers in the United States.

Jesse D Schold1, Kenneth A Andreoni2, Anil K Chandraker3, Robert S Gaston4, Jayme E Locke4, Amit K Mathur5, Timothy L Pruett6, Abbas Rana7, Lloyd E Ratner8, Laura D Buccini9.   

Abstract

Outcomes of patients receiving solid organ transplants in the United States are systematically aggregated into bi-annual Program-Specific Reports (PSRs) detailing risk-adjusted survival by transplant center. Recently, the Scientific Registry of Transplant Recipients (SRTR) issued 5-tier ratings evaluating centers based on risk-adjusted 1-year graft survival. Our primary aim was to examine the reliability of 5-tier ratings over time. Using 10 consecutive PSRs for adult kidney transplant centers from June 2012 to December 2016 (n = 208), we applied 5-tier ratings to center outcomes and evaluated ratings over time. From the baseline period (June 2012), 47% of centers had at least a 1-unit tier change within 6 months, 66% by 1 year, and 94% by 3 years. Similarly, 46% of centers had at least a 2-unit tier change by 3 years. In comparison, 15% of centers had a change in the traditional 3-tier rating at 3 years. The 5-tier ratings at 4 years had minimal association with baseline rating (Kappa 0.07, 95% confidence interval [CI] -0.002 to 0.158). Centers had a median of 3 different 5-tier ratings over the period (q1 = 2, q3 = 4). Findings were consistent for center volume, transplant rate, and baseline 5-tier rating. Cumulatively, results suggest that 5-tier ratings are highly volatile, limiting their utility for informing potential stakeholders, particularly transplant candidates given expected waiting times between wait listing and transplantation.
© 2018 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  ethics and public policy; graft survival; health services and outcomes research; kidney transplantation/nephrology; organ transplantation in general; patient education; statistics

Year:  2018        PMID: 29316241     DOI: 10.1111/ajt.14659

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  7 in total

1.  The relationship between the C-statistic and the accuracy of program-specific evaluations.

Authors:  Andrew Wey; Nicholas Salkowski; Bertram L Kasiske; Melissa A Skeans; Sally K Gustafson; Ajay K Israni; Jon J Snyder
Journal:  Am J Transplant       Date:  2018-10-29       Impact factor: 8.086

2.  Comparing Scientific Registry of Transplant Recipients posttransplant program-specific outcome ratings at listing with subsequent recipient outcomes after transplant.

Authors:  Andrew Wey; Nicholas Salkowski; Bertram L Kasiske; Melissa Skeans; Cory R Schaffhausen; Sally K Gustafson; Ajay K Israni; Jon J Snyder
Journal:  Am J Transplant       Date:  2018-08-31       Impact factor: 8.086

3.  High Dimensional Renal Profiling: Towards a Better Understanding or Renal Transplant Immune Suppression.

Authors:  Cyd M Castro-Rojas; Rita R Alloway; E Steve Woodle; David A Hildeman
Journal:  Curr Transplant Rep       Date:  2019-01-14

4.  A Composite End Point of Graft Status and eGFR at 1 Year to Improve the Scientific Registry of Transplant Recipients' Five-Tier Rating System.

Authors:  Kaicheng Wang; Yanhong Deng; Darren Stewart; Richard N Formica
Journal:  J Am Soc Nephrol       Date:  2022-05-10       Impact factor: 14.978

5.  Seeking new answers to old questions about public reporting of transplant program performance in the United States.

Authors:  Bertram L Kasiske; Andrew Wey; Nicholas Salkowski; David Zaun; Cory R Schaffhausen; Ajay K Israni; Jon J Snyder
Journal:  Am J Transplant       Date:  2018-09-06       Impact factor: 8.086

6.  Variation in Racial Disparities in Liver Transplant Outcomes Across Transplant Centers in the United States.

Authors:  Katherine Ross-Driscoll; Michael Kramer; Raymond Lynch; Laura Plantinga; Joel Wedd; Rachel Patzer
Journal:  Liver Transpl       Date:  2020-12-11       Impact factor: 5.799

7.  Impact of Extending Eligibility for Reinstatement of Waiting Time After Early Allograft Failure: A Decision Analysis.

Authors:  S Ali Husain; Kristen L King; Joel T Adler; Sumit Mohan; Rimma Perotte
Journal:  Am J Kidney Dis       Date:  2021-09-22       Impact factor: 8.860

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.